We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.58%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.77B
AUM Growth
-$242M
(-8%)
Cap. Flow
-$349M
Cap. Flow
% of AUM
-12.6%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$30.5M |
| 2 |
AdaptHealth
AHCO
|
+$26.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$19.6M |
| 4 |
BJ's Restaurants
BJRI
|
+$17.7M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$35.4M |
| 2 |
New Fortress Energy
NFE
|
+$28.3M |
| 3 |
Immunovant
IMVT
|
+$27.9M |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$25M |
| 5 |
Taylor Morrison
TMHC
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.04% |
| 2 | Technology | 19.82% |
| 3 | Consumer Discretionary | 16.91% |
| 4 | Industrials | 13.94% |
| 5 | Financials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CrowdStrike
CRWD
$202B
| $993K | 0.04% |
21,756
-9,720
| -31% | -$514K |
|
152
EPAM Systems
EPAM
$4.67B
| $964K | 0.03% |
2,430
-550
| -18% | -$201K |
|
153
Teradyne
TER
$52.2B
| $953K | 0.03% |
7,830
+2,150
| +38% | +$270K |
|
|
CTLT
154
DELISTED
CATALENT, INC.
CTLT
| $944K | 0.03% |
8,965
-400
| -4% | -$44.6K |
|
155
Pinnacle Financial Partners Inc
PNFP
$15B
| $938K | 0.03% |
10,580
| – | – |
|
|
PPLI
156
People Inc
PPLI
$3.33B
| $929K | 0.03% |
7,869
-312
| -4% | -$38.7K |
|
157
Pinterest
PINS
$12.8B
| $921K | 0.03% |
12,442
-520
| -4% | -$38.7K |
|
|
PLAN
158
DELISTED
Anaplan, Inc.
PLAN
| $895K | 0.03% |
16,629
+800
| +5% | +$54K |
|
159
Booking.com
BKNG
$139B
| $892K | 0.03% |
9,575
| – | – |
|
|
BBBY
160
Bed Bath & Beyond
BBBY
$477M
| $877K | 0.03% |
14,567
-3,718
| -20% | -$252K |
|
161
Twilio
TWLO
$31.2B
| $865K | 0.03% |
2,539
-90
| -3% | -$33.7K |
|
|
EBIX
162
DELISTED
Ebix Inc
EBIX
| $834K | 0.03% |
+26,040
| New | +$1M |
|
163
AutoZone
AZO
$48.9B
| $831K | 0.03% |
592
-30
| -5% | -$37.1K |
|
164
Roku
ROKU
$21.4B
| $817K | 0.03% |
2,507
-90
| -3% | -$35.3K |
|
165
Ionis Pharmaceuticals
IONS
$8.75B
| $792K | 0.03% |
+17,621
| New | +$983K |
|
166
Moderna
MRNA
$23.6B
| $792K | 0.03% |
6,046
+690
| +13% | +$100K |
|
167
Chipotle Mexican Grill
CMG
$42.5B
| $772K | 0.03% |
27,150
-36,250
| -57% | -$1.05M |
|
|
ZEN
168
DELISTED
ZENDESK INC
ZEN
| $766K | 0.03% |
5,774
+1,152
| +25% | +$165K |
|
169
Williams-Sonoma
WSM
$26.3B
| $755K | 0.03% |
+8,422
| New | +$569K |
|
170
lululemon athletica
LULU
$13.2B
| $724K | 0.03% |
2,359
-80
| -3% | -$26.3K |
|
171
Owens Corning
OC
$11.3B
| $718K | 0.03% |
7,799
-7,075
| -48% | -$593K |
|
172
Visa
V
$686B
| $709K | 0.03% |
3,349
-450
| -12% | -$94.7K |
|
|
AGS
173
DELISTED
PlayAGS
AGS
| $686K | 0.02% |
+84,954
| New | +$605K |
|
|
SBNY
174
DELISTED
Signature Bank
SBNY
| $668K | 0.02% |
+2,956
| New | +$582K |
|
|
HES
175
DELISTED
Hess
HES
| $666K | 0.02% |
+9,418
| New | +$602K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.
- Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
- Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
- Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
- Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
- Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
- Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.
Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.